Focus
Therapeutics Investors: Angels and VC Firms
The RaiseHunt database lists 4,956 Therapeutics investors: 410 angel investors and 4,546 people at 870 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,956
- Therapeutics investors
- 410
- Angel investors
- 4,546
- People at VC/PE firms
- 870
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,956 Therapeutics investors
Showing 181-200
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Stefan Fischer Managing Partner (Finance) bei TVM Capital Life Science at TVM Capital Life Science | Munich, Germany | Venture capital | ConsumerHardware | ||
 Karin Rabe Investmentmanager at Bm-t Beteiligungsmanagement Thüringen | Erfurt, Germany | Private equityVenture capital | AIHardware | ||
 Matthew Hammond Partner at RA Capital Management | Boston, United States | Private equityVenture capital | FinTechHealthcare | ||
 Jack Slaughter Principal at Mountain Group Partners | Nashville, United States | Private equityVenture capital | ClimateConsumer | ||
 Catherine Boule Managing Partner at Karista | Paris, France | Venture capital | AIConsumer | ||
 Aaron Jacobson Director at Juvo Ventures | San Francisco, United States | Venture capital | AICommerce | ||
 Kevin Bitterman Partner at Atlas Venture | Cambridge, United States | Venture capital | CommerceConsumer | ||
 Minglin Ma Executive Director at Vertex Pharmaceuticals | Ithaca, United States | Corporate VCFamily Office | AIClimate | ||
 George Petrocheilos Co-Founder & Managing Partner at Catalio Capital Management | New York, United States | Venture capitalVenture debt | AIHealthcare | ||
 William Cohn Professor of Surgery at Baylor College of Medicine (Immunology, Allergy & Rheumatology) | Bellaire, United States | Corporate VCVenture capital | AIHealthcare | ||
 Phillip Samayoa Venture Partner at Atlas Venture | Cambridge, United States | Venture capital | CommerceConsumer | ||
 Yifan Lai Principal at Wellington Management | New York, United States | Private equityVenture debt | AIClimate | ||
 Sai Abhishek Vice President at Enavate Sciences | New York, United States | Venture capital | Healthcare | ||
 David Motley Managing Partner & Co-Founder at BlueTree Venture Fund | Pittsburgh, United States | Venture capital | CommerceConsumer | ||
 Gary Bornstein Program Manager at Point72 | New York City, United States | Private equityVenture debt | AIClimate | ||
 Matthew J. Hobson Principal at Catalio Capital Management | New York, United States | Venture capitalVenture debt | AIHealthcare | ||
 Hui Cheng Principal, Digital Health at New Enterprise Associates (NEA) | San Francisco, United States | Venture capital | AICommerce | ||
 David Siet Principal at Amzak Health Investors | New York, United States | Private equityVenture capital | Healthcare | ||
 Albert Shyy Managing Director at Eurazeo | Singapore | Fund of fundsPrivate equity | AICommerce | ||
 Cassidy Leventhal Principal at Achieve Partners | New York, United States | Corporate VCVenture capital | AIConsumer |
Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal